FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Van Der Perk, M. E. Madeleine; Broer, Linda; Yasui, Yutaka et al.
INTER-INDIVIDUAL VARIATION IN GONADOTOXICITY IN FEMALE CHILDHOOD CANCER SURVIVORS - A GENOME-WIDE ASSOCIATION STUDY: RESULTS FROM THE PANCARELIFE STUDYPEDIATRIC BLOOD & CANCER. Bd. 70. 2023 S. S130-S131
Hartig, Renee; Karimi, Ali; Evrard, Henry C.
Interconnected sub-networks of the macaque monkey gustatory connectomeFRONTIERS IN NEUROSCIENCE. Bd. 16. 2023
Jorg, Tobias; Mildenberger, Peter; Stoehr, Fabian
Interdisciplinary case discussionsRADIOLOGIE. 2023
Reith, W.; Mildenberger, P.; Herold, C. et al.
Interdisciplinary Discussions, Consultative Findings and Communication of ResultsRADIOLOGIE. Bd. 63. H. 2. 2023 S. 87-88
Lahmer, T.; Stock, K.; Rasch, S. et al.
Interdisciplinary ultrasound-guided, minimally invasive autopsy in COVID-19-deceased patients in the intensive care unit of a university hospital. A proof-of-concept studyPATHOLOGIE. Bd. 44. H. 3. 2023 S. 193-197
Klemperer, David; Lieb, Klaus
Interessenkonflikte und LeitlinienC. Günster,J. Klauber, D. Klemperer, M. Nothacker, B.-P. Robra, C. Schmucker (Hrsg). Versorgungs-Report Leitlinien - Evidenz für die Praxis. Medizinisch Wissenschaftliche Verlagsgesellschaft 2023
Bartsch, Rupert; Harbeck, Nadia; Wrobel, Denise et al.
Interim analysis (n=200) from ELEANOR: a multinational, prospective, non-interventional study among patients with HER2+and HR+ early breast cancer treated with extended adjuvant neratinib in the clinical routineCANCER RESEARCH. Bd. 83. H. 5. 2023
Bartsch, R.; Harbeck, N.; Wrobel, D. et al.
Interim analysis (n=200) of ELEANOR: a multi-national, prospective, non-interventional study among patients with HER2+and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib in the clinical routineONCOLOGY RESEARCH AND TREATMENT. Bd. 46. 2023 S. 170-171
Bartsch, R.; Harbeck, N.; Wrobel, D. et al.
Interim analysis of ELEANOR (n=200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+and HR+ early breast cancer (eBC) treated with extended adjuvant neratinibBREAST. Bd. 68. 2023 S. S20-S21
Houbiers, Jos G.; Chvatchko, Yolande; Maki, Markku et al.
INTERIM RESULTS FROM A FIRST-IN-HUMAN STUDY OF THE ANTI-IL-15 ANTIBODY CALY-002 FOR TREATING CELIAC DISEASE AND EOSINOPHILIC ESOPHAGITISGASTROENTEROLOGY. Bd. 164. H. 6. 2023 S. S217-S218